Lijun I. Ning

145 Middle Shandong Road
Shanghai, 200001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Cross-kingdom metabolic interactions govern Candida albicans overgrowth and colitis progression.

Cross-kingdom metabolic interactions govern Candida albicans overgrowth and colitis progression.

Journal: Cell host & microbe
Published: October 09, 2025

Microbial phosphoketolase promotes histone lactylation to improve anti-TNF therapy efficacy in inflammatory bowel disease.

Microbial phosphoketolase promotes histone lactylation to improve anti-TNF therapy efficacy in inflammatory bowel disease.

Journal: Cell metabolism
Published: September 21, 2025

Gut pathogen Clostridium symbiosum rewires macrophage succinylation to drive enteric neuron loss in inflammatory bowel disease.

Gut pathogen Clostridium symbiosum rewires macrophage succinylation to drive enteric neuron loss in inflammatory bowel disease.

Journal: Cell host & microbe
Published: September 03, 2025

Willingness of General Practitioners to Enhance Working Competence in Community Healthcare Centers in Shanghai.

Willingness of General Practitioners to Enhance Working Competence in Community Healthcare Centers in Shanghai.

Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
Published: March 13, 2025

Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease.

Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease.

Journal: Journal of Crohn's & colitis
Published: March 11, 2025

Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype.

Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype.

Journal: Cell reports
Published: August 01, 2024

Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn's disease.

Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn's disease.

Journal: Cell metabolism
Published: July 30, 2024

Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy.

Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy.

Journal: Cell metabolism
Published: July 02, 2024

Gut microbial β-Glucuronidase: A key regulator of endobiotic homeostasis.

Gut microbial β-Glucuronidase: A key regulator of endobiotic homeostasis.

Journal: Cell host & microbe
Published: May 08, 2024

Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses.

Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses.

Journal: Cell metabolism
Published: April 14, 2024

Gut microbiome ecological topology as next-generation biomarkers for cancer immunotherapy.

Gut microbiome ecological topology as next-generation biomarkers for cancer immunotherapy.

Journal: Cell
Published: April 07, 2024

Publisher Correction: Knockdown of ANXA10 induces ferroptosis by inhibiting autophagy-mediated TFRC degradation in colorectal cancer.

Publisher Correction: Knockdown of ANXA10 induces ferroptosis by inhibiting autophagy-mediated TFRC degradation in colorectal cancer.

Journal: Cell death & disease
Published: October 16, 2023
Showing 1-12 of 19

Last Updated: 09/26/2026